Form 4: Orthofix Medical Inc. Director Michael Finegan Acquires Deferred Stock Units

Director Michael Finegan acquired 8,350 deferred stock units of Orthofix Medical Inc. on January 31, 2024.

Summary

• On January 31, 2024, Michael Finegan, a director of Orthofix Medical Inc., acquired 8,350 deferred stock units.
• These deferred stock units vest in full on the earlier of June 30, 2024, or the date of the company's 2024 annual meeting of stockholders, contingent upon continued service.
• Each deferred stock unit represents a contingent right to receive one share of Orthofix Medical Inc. common stock.
• Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing regarding stock ownership. There is no inherent positive or negative sentiment.

Future Outlook

The deferred stock units will vest on the earlier of June 30, 2024, or the date of the 2024 annual meeting, contingent upon continued service, and will be settled within 45 days of service termination.

Industry Context

This filing is a routine disclosure of a director's acquisition of deferred stock units, a common form of executive compensation in publicly traded companies.

Stakeholder Impact

• The acquisition of deferred stock units by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates